iblamemyphiltrum
Iron
- Joined
- Nov 21, 2025
- Posts
- 60
- Reputation
- 40
Romosozumab increases bone formation by inhibiting sclerostin, and this mechanism can increase bone mass in any individual, regardless of baseline bone density. Though when not prescribed it’s hard to get your hands on.
Here’s a study:
pubmed.ncbi.nlm.nih.gov
Here’s a study:
Romosozumab improves lumbar spine bone mass and bone strength parameters relative to alendronate in postmenopausal women: results from the Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial - PubMed
The Active-Controlled Fracture Study in Postmenopausal Women With Osteoporosis at High Risk (ARCH) trial (NCT01631214; https://clinicaltrials.gov/ct2/show/NCT01631214) showed that romosozumab for 1 year followed by alendronate led to larger areal bone mineral density (aBMD) gains and superior...